ArticleJournal for immunotherapy of cancer2026
Toward precision adjuvant immunotherapy in high-risk clear cell renal cell carcinoma: integrating plasma multiomics with PD-1 blockade.
Rakesh Kumar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.